What is gait speed, and why is it used as a clinical outcome?
Gait speed is the distance a person walks divided by the time taken, reported in meters per second and usually measured at usual pace over a marked 4-meter or 10-meter course. It is used as an outcome because it is quick, reliable, and predicts mortality, disability, and hospitalization, which led to its description as the sixth vital sign.
Last reviewed .
How gait speed is measured
A distance is marked, the patient walks it, and the time is recorded. Speed is distance divided by time. The measurement is simple, which is much of its value, but the details determine whether two measurements can be compared.
- Distance — 4 m and 10 m courses are the most common; longer distances are used when endurance rather than speed is the question.
- Pace instruction — usual, comfortable pace is the standard condition, and most published thresholds refer to it. Maximum-pace speed is a separate measure.
- Acceleration and deceleration — these are normally excluded from the timed segment so the result reflects steady-state walking.
- Repetition — repeated passes are averaged, because a single trial is a noisy estimate.
Why it is treated as a vital sign
Walking requires the cardiovascular, respiratory, musculoskeletal, and nervous systems to work together, so a single number summarising how well someone walks reflects a great deal about their overall state. A pooled analysis published in JAMA found gait speed to be associated with survival in older adults.
Reviews of the measure describe it as valid, reliable, and sensitive to change across a wide range of populations, which is the basis for the sixth vital sign designation.
Published thresholds
Thresholds are reference points drawn largely from older and hospitalised cohorts. They are not universal cut-offs, and they should be read against the population in front of you.
| Approximate threshold | How it is commonly interpreted |
|---|---|
| 1.2–1.4 m/s | Typical usual-pace walking speed for healthy adults. |
| Below about 1.0 m/s | Used as a yellow flag in older adults, prompting closer evaluation. |
| 0.8 m/s or below | The threshold adopted by the revised European sarcopenia consensus as an indicator of low physical performance, and widely used in frailty screening. |
| Below about 0.6 m/s | Associated with more severe functional impairment in the literature. |
Thresholds derived from geriatric and hospital cohorts should not be applied unchanged to working-age or musculoskeletal populations.
How much change is meaningful
A change only counts if it exceeds measurement error. Work on responsiveness in common physical performance measures described roughly 0.05 m/s as a small meaningful change and roughly 0.10 m/s as a substantial meaningful change in older adults.
Minimal detectable change values vary by population and by baseline function, so the relevant figure depends on the cohort being followed rather than on gait speed as a measure in general.
Where CurveAssure fits
Walking speed is one of the parameters CurveAssure derives from the recorded walk, alongside cadence, stride length, and stride time. It is measured from video in a hallway rather than by hand with a stopwatch, using the same processing on every recording.
CurveAssure reports measurements. Interpretation against any threshold, and any decision that follows, rests with the healthcare provider.
References
- Fritz S, Lusardi M. White paper: walking speed — the sixth vital sign. Journal of Geriatric Physical Therapy, 2009. https://pubmed.ncbi.nlm.nih.gov/20039582/
- Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. Journal of Aging and Physical Activity, 2015. https://pmc.ncbi.nlm.nih.gov/articles/PMC4254896/
- Studenski S, Perera S, Patel K, et al.. Gait speed and survival in older adults. JAMA, 2011. https://doi.org/10.1001/jama.2010.1923
- Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. Journal of the American Geriatrics Society, 2006. https://doi.org/10.1111/j.1532-5415.2006.00701.x
- Bohannon RW, Williams Andrews A. Normal walking speed: a descriptive meta-analysis. Physiotherapy, 2011. https://doi.org/10.1016/j.physio.2010.12.004
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al.. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age and Ageing, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6322506/